These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 34470547)

  • 1. Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust.
    Hinton R; Nesr G; Garnett C; Foldes D; McCay JJR; Medland R; Kagdi H; Katsomitrou V; Sim HW; Gandhi S; Parcharidou A; Arami S
    Leuk Lymphoma; 2022 Jan; 63(1):227-230. PubMed ID: 34470547
    [No Abstract]   [Full Text] [Related]  

  • 2. The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    Gardiner T; Cooke G; Fidler S; Cooper N; Young L
    J Infect; 2021 Apr; 82(4):84-123. PubMed ID: 33189774
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.
    Garnett C; Foldes D; Bailey C; Nesr G; Hui T; Hinton R; Gurung K; Phillips J; Saleem Z; Koshy R; Aduwa E; Colis M; Bimolah R; Katsomitrou V; Arami S; Kagdi H
    Leuk Lymphoma; 2021 Feb; 62(2):469-472. PubMed ID: 33167718
    [No Abstract]   [Full Text] [Related]  

  • 4. The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London.
    Crocker-Buque T; Williams S; Brentnall AR; Gabe R; Duffy S; Prowle JR; Orkin C; Kunst H; Cutino-Moguel T; Zenner D; Bloom B; Melzer M; de Freitas S; Darmalingam M; McCafferty K; Kapil V; Pfeffer P; Martin J; Gourtsoyannis Y; Chandran S; Dhariwal A; Rachman R; Milligan I; Mabayoje D; Adobah E; Falconer J; Nugent H; Yaqoob M; Collier D; Pearse R; Caulfield M; Tiberi S
    Int J Tuberc Lung Dis; 2021 May; 25(5):358-366. PubMed ID: 33977903
    [No Abstract]   [Full Text] [Related]  

  • 5. Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting.
    Varettoni M; Mangiacavalli S; Rattotti S; Cartia CS; Cavalloni C; Rossetti F; Ferretti VV; Bergamini F; Trotti C; Fiorelli N; Pagani G; Zerbi C; Ferrari J; Cristinelli C; Muzzi A; Marena C; Baldanti F; Bruno R; Arcaini L
    Leuk Lymphoma; 2021 Dec; 62(13):3311-3312. PubMed ID: 34261423
    [No Abstract]   [Full Text] [Related]  

  • 6. SARS-CoV-2 infection and mortality in pediatric patients with hematological malignancies and solid tumors.
    Aguiar JEAT; Carvalho MAL; Viana SS; Martins-Filho PR; Cipolotti R
    Pediatr Hematol Oncol; 2023 May; 40(4):429-432. PubMed ID: 36094799
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies.
    Ferrari S; Caprioli C; Weber A; Rambaldi A; Lussana F
    Leuk Lymphoma; 2021 Jun; 62(6):1490-1496. PubMed ID: 33461387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
    Re D; Barrière J; Chamorey E; Delforge M; Gastaud L; Petit E; Chaminade A; Verrière B; Peyrade F
    Leuk Lymphoma; 2021 Dec; 62(13):3308-3310. PubMed ID: 34308748
    [No Abstract]   [Full Text] [Related]  

  • 9. A demand-capacity mismatch between rehabilitation need and service provision as a result of the COVID-19 pandemic? Early clinical observations from a large teaching hospital in London.
    Tahtis V; Wilson N; Northfield F; Cook D; Gregory K; Reilly CC
    Physiotherapy; 2021 Dec; 113():153-159. PubMed ID: 34563381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
    Blennow O; Salmanton-García J; Nowak P; Itri F; Van Doesum J; López-García A; Farina F; Jaksic O; Pinczés LI; Bilgin YM; Falces-Romero I; Jiménez M; Ormazabal-Vélez I; Weinbergerová B; Duléry R; Stojanoski Z; Lahmer T; Fernández N; Hernández-Rivas JÁ; Petzer V; De Jonge N; Glenthøj A; De Ramón C; Biernat MM; Fracchiolla N; Aujayeb A; Van Praet J; Schönlein M; Méndez GA; Cattaneo C; Guidetti A; Sciumè M; Ammatuna E; Cordoba R; García-Poutón N; Gräfe S; Cabirta A; Wolf D; Nordlander A; García-Sanz R; Delia M; Berg Venemyr C; Brones C; Di Blasi R; De Kort E; Meers S; Lamure S; Serrano L; Merelli M; Coppola N; Bergantim R; Besson C; Kohn M; Petiti J; Garcia-Vidal C; Dargenio M; Danion F; Machado M; Bailén-Almorox R; Hoenigl M; Dragonetti G; Chai LYA; Kho CS; Bonanni M; Liévin R; Marchesi F; Cornely OA; Pagano L
    Am J Hematol; 2022 Aug; 97(8):E312-E317. PubMed ID: 35702878
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
    Morales-Ortega A; García de Tena J; Frutos-Pérez B; Jaenes-Barrios B; Farfán-Sedano AI; Canales-Albendea MÁ; Bernal-Bello D
    Cancer; 2021 Jun; 127(11):1937-1938. PubMed ID: 33721325
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
    Cattaneo C; Cairoli R; Rossi G
    Cancer; 2021 Jun; 127(11):1939. PubMed ID: 33721356
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons in cognitive unloading, skills mixing, flattened hierarchy and organisational agility from the Nightingale Hospital London during the first wave of the
    Collins GB; Ahluwalia N; Arrol L; Forrest N; McGlennan A; O'Brien B; Proudfoot A; Trainer M; Schilling R; Sullivan E; Westwood M; Wragg A; Knight C
    BMJ Open Qual; 2021 Jul; 10(3):. PubMed ID: 34301730
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies.
    Gambacorti-Passerini C; Ruggeri M; Aroldi A; Piazza R; Mazzi A; De Silvestro G; Krampera M; Lanza F
    Transfus Apher Sci; 2021 Jun; 60(3):103105. PubMed ID: 33637468
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of hematologic malignancies during the COVID-19 pandemic.
    Hus I; Salomon-Perzyński A; Tomasiewicz K; Robak T
    Expert Opin Pharmacother; 2021 Apr; 22(5):565-582. PubMed ID: 33342308
    [No Abstract]   [Full Text] [Related]  

  • 16. Public Adoption of and Trust in the NHS COVID-19 Contact Tracing App in the United Kingdom: Quantitative Online Survey Study.
    Dowthwaite L; Fischer J; Perez Vallejos E; Portillo V; Nichele E; Goulden M; McAuley D
    J Med Internet Res; 2021 Sep; 23(9):e29085. PubMed ID: 34406960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.
    Greenberger LM; Saltzman LA; Senefeld JW; Johnson PW; DeGennaro LJ; Nichols GL
    Cancer Cell; 2021 Aug; 39(8):1031-1033. PubMed ID: 34331856
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged viral replication in patients with hematologic malignancies hospitalized with COVID-19.
    Garcia-Vidal C; Puerta-Alcalde P; Mateu A; Cuesta-Chasco G; Meira F; Lopera C; Monzo P; Santos-Bravo M; Duenas G; Chumbita M; Garcia-Pouton N; Gaya A; Bodro M; Herrera S; Mosquera M; Fernandez-Aviles F; Martinez JA; Mensa J; Gine E; Marcos MA; Soriano A
    Haematologica; 2022 Jul; 107(7):1731-1735. PubMed ID: 35295080
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 vaccination intent among London healthcare workers.
    Abuown A; Ellis T; Miller J; Davidson R; Kachwala Q; Medeiros M; Mejia K; Manoraj S; Sidhu M; Whittington AM; Pattani S
    Occup Med (Lond); 2021 Aug; 71(4-5):211-214. PubMed ID: 34002797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dentists deployed: an insider's perspective of life on the NHS front line.
    Powell HE
    Prim Dent J; 2021 Sep; 10(3):21-29. PubMed ID: 34727769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.